Cart
sales@molnova.com
DC260126
CAS No. 346692-04-4
DC260126( —— )
Catalog No. M20675 CAS No. 346692-04-4
DC260126 is a small-molecule antagonist of FFA1 (GPR40).
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 45 | In Stock |
|
| 10MG | 59 | In Stock |
|
| 25MG | 130 | In Stock |
|
| 50MG | 204 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameDC260126
-
NoteResearch use only, not for human use.
-
Brief DescriptionDC260126 is a small-molecule antagonist of FFA1 (GPR40).
-
DescriptionDC260126 is a small-molecule antagonist of FFA1 (GPR40) .
-
In VitroDC260126 reduces GTP-loading and ERK1/2 phosphorylation stimulated by linoleic acid in GPR40-CHO cells, suppresses palmitic acid potentiated glucose-stimulated insulin secretion, and negatively regulates GPR40 mRNA expression induced by oleic acid in Min6 cells.
-
In Vivo——
-
Synonyms——
-
PathwayCell Cycle/DNA Damage
-
TargetGPR
-
RecptorGPR40
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number346692-04-4
-
Formula Weight307.38
-
Molecular FormulaC16H18FNO2S
-
Purity>98% (HPLC)
-
SolubilityDMSO:100 mg/mL (325.33 mM)
-
SMILESCCCCc1ccc(NS(=O)(=O)c2ccc(F)cc2)cc1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Peng S Ting W Yuren Z et al. DC260126: A Small-Molecule Antagonist of GPR40 that Protects against Pancreatic β-Cells Dysfunction in db/db Mice[J]. PLoS ONE 2013 8(6):e66744-.
molnova catalog
related products
-
GPR35 agonist 2
GPR35 agonist 2 (TC-G 1001) is a potent GPR35 agonist.The EC50 values of GPR35 agonist 2 in the β-arrestin and Ca2+ release assays were 26 and 3.2 nM, respectively.
-
Myristyl nicotinate
Myristyl nicotinate is an ester prodrug being developed for delivery of nicotinic acid (NIC) into the skin for prevention of actinic keratosis and its progression to skin cancer.
-
GLPG1205
GLPG1205 is a potent, orally active GPR84 (G protein-coupled receptor) antagonist with anti-inflammatory activity. GLPG1205 shows good PK/PD characteristics and can be used to study pulmonary fibrosis.
